Hormone Replacement Therapy (HRT) Market 2028 By Product Replacement Therapy, Route Of Administration, Type of Disease and Geography | The Insight Partners

report image

Hormone Replacement Therapy (HRT) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, Other Hormone Replacement Therapy); Route Of Administration (Oral, Parenteral, Transdermal); Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Others) and Geography

Report Code: TIPRE00003836 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Hormone replacement therapy (HRT) is the use of hormones to replace natural hormones when the body does not make them enough. For instance, hormone replacement therapy may be given to thyroid patients , menopause patients, several cancer patients, growth hormone deficiency patients etc. Furthermore, HRT was often administered to menopausal women for the relief of symptoms such as hot flushes, night sweats, sleep disturbances, psychological and genito-urinary disorders (urinary frequency and vaginal dryness), as well as the prevention of osteoporosis.


The "Global Hormone Replacement Therapy (HRT) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the hormone replacement therapy (HRT) market with detailed market segmentation by product, route of administration and type of disease. The report provides key statistics on the market status of the leading hormone replacement therapy (HRT) market players and offers key trends and opportunities in the market.


  •   Based on product the market is segmented as, estrogen replacement therapy, human growth hormone (HGH) replacement therapy, thyroid replacement therapy, testosterone replacement therapy, other hormone replacement therapy.
  •   Based on route of administration the market is segmented as, oral, parenteral and transdermal.
  •   Based on type of disease the market is segmented as, menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, others.



  •   Increasing prevalence of hormonal imbalance disorders and menopausal disorders.
  •   Advancements in hormone replacement therapies and growing R&D activities to develop more precise hormone replacement therapies.
  •   New product launches and higher demand for hormone replacement therapies to treat conditions like cancers, sexual disorders, growth related disorders.


  •   However, high cost of hormone replacement therapy is likely to restrain market growth during the forecast period.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The hormone replacement therapy (HRT) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the hormone replacement therapy (HRT) market in these regions.

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. The hormone replacement therapy market has been negatively impacted by the implementation of lockdown. In addition, the novel coronavirus exhibits a wide spectrum of clinical presentations, severity, and mortality rates. Furthermore, postmenopausal fertility treatment has been impacted by the pandemic, with research suggesting that dropping estrogen levels may put older women at greater risk of the disease, as well as the possibility that hormone withdrawal may accelerate COVID-19 progression.


The report covers key developments in the hormone replacement therapy (HRT) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from hormone replacement therapy (HRT) market are anticipated to lucrative growth opportunities in the future with the rising demand for hormone replacement therapy (HRT) in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the hormone replacement therapy (HRT) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Pfizer Inc.
  •   Abbott
  •   Novo Nordisk
  •   Novartis Pharmaceuticals Corporation.
  •   Merck KGaA
  •   Bayer AG
  •   Lilly
  •   Mylan N.V
  •   Cyndea Pharma
  •   Genentech, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

- Pfizer Inc.
- Abbott
- Novo Nordisk
- Novartis Pharmaceuticals Corporation.
- Merck KGaA
- Bayer AG
- Lilly
- Mylan N.V
- Cyndea Pharma
- Hisamitsu Pharmaceutical Co.,Inc
- Cipla, Inc
- Abbvie, Inc
- Glenmark Pharmaceutical Inc., USA
- Sun Pharmaceuticals, Inc
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount